Singapore, March 14 -- The L V Prasad Eye Institute (LVPEI), Hyderabad, India has been granted an Australian patent for a novel cell therapy that can be used to repair damaged corneas from a variety of corneal diseases. This unique 'cell composition' based therapy marks a significant milestone in the field of ophthalmology and cell-based therapies.

The patent is granted for the advanced cell compositions comprising limbal epithelial and stromal cells for treating and preventing corneal diseases, along with their production methods and therapeutic applications.

The therapy has previously been granted a patent by the Patent Office, Government of India, for a period of 20 years in accordance with the provisions of the Patents Act, 1970. Go...